Human Molecular Genetics, 2000, Vol. 9, No. 2 237-247
© 2000 Oxford University Press
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
Medical and Molecular Genetics Center—IRO, Hospital Duran i Reynals, Avia. Castelldefels, Km 2.7, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
Neurofibromatosis type 1 (NF1) is one of the most common inherited disorders in humans and is caused by mutations in the NF1 gene. To date, the majority of the reported NF1 mutations are predicted to result in protein truncation, but very few studies have correlated the causative NF1 mutation with its effect at the mRNA level. We have applied a whole NF1 cDNA screening methodology to the study of 80 unrelated NF1 patients and have identified 44 different mutations, 32 being novel, in 52 of these patients. Mutations were detected in 87% of the familial cases, but in 51% of the sporadic ones. At least 15 of the 80 NF1 patients (19%) had recurrent mutations. The study shows that in 50% of the patients in whom the mutations were identified, these resulted in splicing alterations. Most of the splicing mutations did not involve the conserved AG/GT dinucleotides of the splice sites. One frameshift, two nonsense and two missense mutations were also responsible for alterations in mRNA splicing. The location and type of mutation within the NF1 gene, and its putative effect at the protein level, do not indicate any relationship to any specific clinical feature of NF1. The high proportion of aberrant spliced transcripts detected in NF1 patients stresses the importance of studying mutations at both the genomic and RNA level. It is possible that part of the clinical variability in NF1 could be due to mutations affecting mRNA splicing, which is the most common molecular defect in NF1.
+ To whom correspondence should be addressed. Tel: +34 93 2607775; Fax: +34 93 2607776; Email: estivill@iro.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Kaufmann, S. Vogt, S. Uhlhaas, D. Stienen, I. Kurth, H. Hameister, E. Mangold, J. Kotting, E. Kaminsky, P. Propping, et al. Analysis of Rare APC Variants at the mRNA Level: Six Pathogenic Mutations and Literature Review J. Mol. Diagn., March 1, 2009; 11(2): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Masuda, X.-M. Shen, M. Ito, T. Matsuura, A. G. Engel, and K. Ohno hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome Hum. Mol. Genet., December 15, 2008; 17(24): 4022 - 4035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Kehrer-Sawatzki and D N Cooper Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? J. Med. Genet., October 1, 2008; 45(10): 622 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Iossifov, T. Zheng, M. Baron, T. C. Gilliam, and A. Rzhetsky Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network Genome Res., July 1, 2008; 18(7): 1150 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Goina, N. Skoko, and F. Pagani Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant Mol. Cell. Biol., June 1, 2008; 28(11): 3850 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aartsma-Rus and G.-J. B. van Ommen Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications RNA, October 1, 2007; 13(10): 1609 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Akker, S. Misra, S. Aslam, E. L. Morgan, P. J. Smith, B. Khoo, and S. L. Chew Pre-Spliceosomal Binding of U1 Small Nuclear Ribonucleoprotein (RNP) and Heterogenous Nuclear RNP E1 Is Associated with Suppression of a Growth Hormone Receptor Pseudoexon Mol. Endocrinol., October 1, 2007; 21(10): 2529 - 2540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Buratti, M. Chivers, J. Kralovicova, M. Romano, M. Baralle, A. R. Krainer, and I. Vorechovsky Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization Nucleic Acids Res., July 26, 2007; 35(13): 4250 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Raponi, F. E. Baralle, and F. Pagani Reduced splicing efficiency induced by synonymous substitutions may generate a substrate for natural selection of new splicing isoforms: the case of CFTR exon 12 Nucleic Acids Res., January 28, 2007; 35(2): 606 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vorechovsky Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization Nucleic Acids Res., September 15, 2006; (2006) gkl535v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Spena, M. L. Tenchini, and E. Buratti Cryptic splice site usage in exon 7 of the human fibrinogen B{beta}-chain gene is regulated by a naturally silent SF2/ASF binding site within this exon RNA, June 1, 2006; 12(6): 948 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Disset, C.F. Bourgeois, N. Benmalek, M. Claustres, J. Stevenin, and S. Tuffery-Giraud An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements Hum. Mol. Genet., March 15, 2006; 15(6): 999 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K K Mantripragada, A-C Thuresson, A Piotrowski, T Diaz de Stahl, U Menzel, G Grigelionis, R E Ferner, S Griffiths, L Bolund, V Mautner, et al. Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH J. Med. Genet., January 1, 2006; 43(1): 28 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kralovicova, M. B. Christensen, and I. Vorechovsky Biased exon/intron distribution of cryptic and de novo 3' splice sites Nucleic Acids Res., September 1, 2005; 33(15): 4882 - 4898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Pagani, M. Raponi, and F. E. Baralle Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution PNAS, May 3, 2005; 102(18): 6368 - 6372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L M Messiaen and K Wimmer Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1 J. Med. Genet., May 1, 2005; 42(5): e25 - e25. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Zahler, J. D. Tuttle, and A. D. Chisholm Genetic Suppression of Intronic +1G Mutations by Compensatory U1 snRNA Changes in Caenorhabditis elegans Genetics, August 1, 2004; 167(4): 1689 - 1696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Mattocks, D Baralle, P Tarpey, C ffrench-Constant, M Bobrow, and J Whittaker Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain J. Med. Genet., April 1, 2004; 41(4): e48 - e48. [Full Text] [PDF]
|
|
|
|
|
|
X. Roca, R. Sachidanandam, and A. R. Krainer Intrinsic differences between authentic and cryptic 5' splice sites Nucleic Acids Res., November 1, 2003; 31(21): 6321 - 6333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, S. Swaminathan, B. K. Martin, and S. K. Sharan Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model Hum. Mol. Genet., September 1, 2003; 12(17): 2121 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Ars, H Kruyer, M Morell, E Pros, E Serra, A Ravella, X Estivill, and C Lazaro Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients J. Med. Genet., June 1, 2003; 40(6): e82 - 82. [Full Text] [PDF]
|
|
|
|
|
|
F. Pagani, C. Stuani, M. Tzetis, E. Kanavakis, A. Efthymiadou, S. Doudounakis, T. Casals, and F. E. Baralle New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12 Hum. Mol. Genet., May 15, 2003; 12(10): 1111 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Krammer, K. Wimmer, P. Wiesbauer, M. Rasse, S. Lang, A. Mullner-Eidenbock, and H. Frisch Neurofibromatosis 1: A Novel NF1 Mutation in an 11-Year-Old Girl With a Giant Cell Granuloma J Child Neurol, May 1, 2003; 18(5): 371 - 373. [Abstract] [PDF]
|
|
|
|
|
|
L Kluwe, M Tatagiba, C Funsterer, and V-F Mautner NF1 mutations and clinical spectrum in patients with spinal neurofibromas J. Med. Genet., May 1, 2003; 40(5): 368 - 371. [Full Text] [PDF]
|
|
|
|
|
|
M Baralle, D Baralle, L De Conti, C Mattocks, J Whittaker, A Knezevich, C ffrench-Constant, and F E Baralle Identification of a mutation that perturbs NF1 agene splicing using genomic DNA samples and a minigene assay J. Med. Genet., March 1, 2003; 40(3): 220 - 222. [Full Text] [PDF]
|
|
|
|
|
|
L Messiaen, V Riccardi, J Peltonen, O Maertens, T Callens, S L Karvonen, E-L Leisti, J Koivunen, I Vandenbroucke, K Stephens, et al. Independent NF1 mutations in two large families with spinal neurofibromatosis J. Med. Genet., February 1, 2003; 40(2): 122 - 126. [Full Text] [PDF]
|
|
|
|
|
|
E S Moreira, M Vainzof, O T Suzuki, R C M Pavanello, M Zatz, and M R Passos-Bueno Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations J. Med. Genet., February 1, 2003; 40(2): e12 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Vacek, H. Ma, F. Gemignani, G. Lacerra, T. Kafri, and R. Kole High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA Blood, January 1, 2003; 101(1): 104 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Majewski and J. Ott Distribution and Characterization of Regulatory Elements in the Human Genome Genome Res., December 1, 2002; 12(12): 1827 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. M. Thomson, L. Fishbein, and M. R. Wallace Review Article : NF1 Mutations and Molecular Testing J Child Neurol, August 1, 2002; 17(8): 555 - 561. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Kaufmann, W. Leistner, P. Kruse, O. Kenner, S. Hoffmeyer, C. Hein, W. Vogel, L. Messiaen, and B. Bartelt Aberrant Splicing in Several Human Tumors in the Tumor Suppressor Genes Neurofibromatosis Type 1, Neurofibromatosis Type 2, and Tuberous Sclerosis 2 Cancer Res., March 1, 2002; 62(5): 1503 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lopez-Correa, M. Dorschner, H. Brems, C. Lazaro, M. Clementi, M. Upadhyaya, D. Dooijes, U. Moog, H. Kehrer-Sawatzki, J. L. Rutkowski, et al. Recombination hotspot in NF1 microdeletion patients Hum. Mol. Genet., June 1, 2001; 10(13): 1387 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Di Blasi, Y. He, L. Morandi, F. Cornelio, P. Guicheney, and M. Mora Mild muscular dystrophy due to a nonsense mutation in the LAMA2 gene resulting in exon skipping Brain, April 1, 2001; 124(4): 698 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Serra, T. Rosenbaum, U. Winner, R. Aledo, E. Ars, X. Estivill, H.-G. Lenard, and C. Lazaro Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations Hum. Mol. Genet., December 1, 2000; 9(20): 3055 - 3064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ars, E. Serra, S. de la Luna, X. Estivill, and C. Lazaro Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA Nucleic Acids Res., March 15, 2000; 28(6): 1307 - 1312. [Abstract] [Full Text] [PDF]
|
|